Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study.

about

Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study.

Item

http://www.wikidata.org/entity/Q42328635

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Efficacy and safety of early t ...... prospective randomized study.

@en

Efficacy and safety of early t ...... prospective randomized study.

@nl

type

Item

label

Efficacy and safety of early t ...... prospective randomized study.

@en

Efficacy and safety of early t ...... prospective randomized study.

@nl

prefLabel

Efficacy and safety of early t ...... prospective randomized study.

@en

Efficacy and safety of early t ...... prospective randomized study.

@nl

P1476

Efficacy and safety of early t ...... prospective randomized study.

@en

P2093

A E El-Agroudy

http://www.w3.org/2001/XMLSchema#string

E Farid

http://www.w3.org/2001/XMLSchema#string

H Alhelow

http://www.w3.org/2001/XMLSchema#string

S Abdulla

http://www.w3.org/2001/XMLSchema#string

S M Al-Ghareeb

http://www.w3.org/2001/XMLSchema#string

S M Alarrayed

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of conversion from calcineurin inhibitor to mammalian target of rapamycin inhibitors for maintenance immunosuppression in kidney transplant recipients

Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.

Immunosuppressive drugs for kidney transplantation.

Immunosuppressive treatment and progression of histologic lesions in kidney allografts.

Immunosuppression: evolution in practice and trends, 1994-2004.

Conversion to sirolimus for chronic renal allograft dysfunction: risk factors for graft loss and severe side effects

Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation.

Calcineurin inhibitor avoidance and withdrawal for kidney transplantation: a systematic review and meta-analysis of randomized controlled trials.

P304

28-36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4103/0971-4065.176146

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28182044

http://www.w3.org/2001/XMLSchema#string

P932

5255987

http://www.w3.org/2001/XMLSchema#string